Akzo Nobel Shareholders To Vote On Organon BioSciences IPO
This article was originally published in The Pink Sheet Daily
Executive Summary
Dutch company’s planned separation of pharmaceuticals business from chemicals/coatings division is expected to be complete in two to three years.